Related Experiment Video

Updated: Jun 2, 2026

Identification of Orexin and Endocannabinoid Receptors in Adult Zebrafish Using Immunoperoxidase and Immunofluorescence Methods
08:37

Identification of Orexin and Endocannabinoid Receptors in Adult Zebrafish Using Immunoperoxidase and Immunofluorescence Methods

Published on: June 25, 2019

Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction

Jaana Putula1, Pauli M Turunen, Lisa Johansson

  • 1Biochemistry and Cell Biology, Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.

FEBS Letters
|April 23, 2011
PubMed

Insights

Investigating orexin (OX) receptors revealed that specific N-terminal regions dictate agonist binding. Modifying transmembrane helices 2-4 significantly altered orexin receptor ligand profiles, impacting OX1 and OX2 receptor distinctions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Orexin receptors (OX1 and OX2) are crucial for regulating sleep-wake cycles and appetite.
  • Understanding the structural basis for selective agonist binding to orexin receptors is essential for developing targeted therapeutics.

Purpose of the Study:

  • To elucidate the structural determinants responsible for the differential binding of agonists to OX1 and OX2 orexin receptors.
  • To analyze the role of specific receptor domains in mediating ligand selectivity.

Main Methods:

  • Generation of chimeric OX1/OX2 and OX2/OX1 orexin receptors.
  • Transient expression of engineered receptors in HEK-293 cells.
  • Measurement of agonist potency via cytosolic calcium (Ca2+) elevation assays.

Main Results:

  • The N-terminal regions of the orexin receptors were identified as critical for agonist discrimination.
  • Exchanging a specific segment from the C-terminal part of transmembrane helix 2 to transmembrane helix 4 resulted in a near-complete shift in the receptor's ligand-binding profile.
  • This structural modification significantly altered the selectivity of orexin-A, orexin-B, and Ala(11), D-Leu(15)-orexin-B.

Conclusions:

  • Structural variations within the N-terminal and specific transmembrane domains of orexin receptors fundamentally govern their interaction with various agonists.
  • Targeted modifications of these regions offer a strategy for modulating orexin receptor pharmacology and developing selective OX1 or OX2 receptor ligands.

More Related Videos

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

Harvesting and Cryo-cooling Crystals of Membrane Proteins Grown in Lipidic Mesophases for Structure Determination by Macromolecular Crystallography18:45

Harvesting and Cryo-cooling Crystals of Membrane Proteins Grown in Lipidic Mesophases for Structure Determination by Macromolecular Crystallography

Published on: September 2, 2012

Related Concept Videos

Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Channel Rhodopsins01:11

Channel Rhodopsins

Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...